| BIOMARIN PHARMACEUTICAL INC | — | 6.7M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Emil D Kakkis | Chief Medical Officer | 536K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Jean Jacques Bienaime | — | 474K | — | — | — | — | — | — | — | — | — | — | -81K | +5K | -8K | -10K | -150K | +91K |
| Christopher M Starr | SVP, Chief Scientific Officer | 423K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Steve Aselage | EVP, Chief Business Officer | 319K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Alexander Hardy | Chief Executive Officer | 215K | — | — | — | +144K | -17K | — | +375 | +103K | -14K | — | — | +77K | +266K | — | — | — |
| Erich Sager | — | 194K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Henry J Fuchs | President, Worldwide R&D | 185K | — | — | — | — | — | — | — | — | — | -12K | +300 | +43K | +18K | -12K | +317 | +83K |
| Jeffrey H Cooper | SVP, Chief Financial Officer | 164K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Franz L Cristiani | — | 135K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Gwynn Williams | — | 135K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Richard A Meier | — | 127K | — | — | — | — | — | — | +7K | — | — | — | +2K | -3K | — | — | -2K | — |
| Brian Mueller | EVP, Chief Financial Officer | 123K | — | — | — | +68K | — | — | — | +67K | — | — | -5K | +51K | — | — | -10K | +47K |
| Robert Baffi | President, Global Mfg/Tech Ops | 117K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Elaine J Heron | — | 102K | — | — | — | — | — | — | — | — | — | — | +552 | — | — | — | -2K | — |
| Charles Greg Guyer | EVP, Chief Technical Officer | 84K | — | — | — | +39K | — | — | — | +43K | -5K | — | -4K | +50K | +12K | -5K | -4K | +27K |
| Fredric D Price | Chief Executive Officer | 79K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Jeffrey Robert Ajer | EVP, Chief Commercial Officer | 67K | — | — | — | — | — | — | — | — | — | — | -5K | +11K | — | -5K | +318 | -2K |
| George Eric Davis | EVP, Chief Legal Officer | 61K | — | -18K | — | +30K | — | — | — | +57K | — | — | -42K | +23K | -14K | -11K | +107 | +44K |
| John Urquhart | — | 60K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| David E I Pyott | — | 50K | — | — | — | — | — | — | — | — | — | — | +5K | — | — | — | +4K | — |
| Robert J. Hombach | — | 49K | — | — | +7K | — | — | — | +7K | — | — | — | +5K | — | — | — | +4K | — |
| Michael G Grey | | 48K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Gregory R Friberg | EVP, Chief R&D Officer | 48K | — | -4K | -3K | +57K | — | -3K | — | +59K | — | +79K | — | — | — | — | — | — |
| Daniel K Spiegelman | EVP, Chief Financial Officer | 48K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Willard H Dere | — | 46K | — | — | +7K | — | — | — | +7K | — | — | — | +5K | — | — | — | +4K | — |
| Cristin Hubbard | EVP, Chief Commercial Officer | 42K | — | — | -2K | +51K | — | — | -2K | +44K | — | — | +53K | — | — | — | — | — |
| Elizabeth M Anderson | — | 42K | — | — | +7K | — | — | — | +7K | — | — | — | +5K | — | — | — | +4K | — |
| Dennis Slamon | — | 41K | — | — | — | — | — | — | — | — | — | — | — | -10K | — | — | +4K | — |
| Maykin Ho | — | 36K | — | — | +7K | — | — | — | +7K | — | — | — | +5K | — | — | — | +4K | — |
| Joseph Klein III | | 35K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Bryan V Lawlis | — | 33K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -4K | — |
| Pierre Lapalme | | 31K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Rashmi Virendra Ramchandani | VP, Chief Accounting Officer | 26K | — | — | — | +44K | — | — | — | — | — | — | — | — | — | — | — | — |
| Alan Lewis | | 26K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Mark Wood | VP, Human Resources | 23K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Barbara W. Bodem | — | 21K | — | — | +7K | — | — | — | +7K | — | — | — | +5K | — | +2K | — | — | — |
| Athena Countouriotis | — | 21K | — | — | +7K | — | — | — | +7K | — | — | — | +5K | — | +2K | — | — | — |
| Mark J Enyedy | — | 21K | — | — | +7K | — | — | — | +7K | — | — | — | +5K | — | +2K | — | — | — |
| Andrea Acosta | GVP, Chief Accounting Officer | 18K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Timothy P Walbert | — | 17K | — | — | +7K | — | — | — | +7K | +3K | — | — | — | — | — | — | — | — |
| Mark J Alles | — | 15K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +4K | — |
| Louis Drapeau | Chief Executive Officer | 15K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Ian T Clark | — | 14K | — | — | +7K | — | — | +7K | — | — | — | — | — | — | — | — | — | — |
| Erin Burkhart | GVP, Chief Accounting Officer | 14K | — | — | — | — | — | — | -3K | +12K | — | -714 | -3K | +11K | — | — | -796 | +9K |
| Stuart J Swiedler | SVP, Clinical Affairs | 13K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| William D Young | | 12K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Kenneth Bate | | 12K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Kathryn E Falberg | | 10K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Robert M Plenge | — | 6K | — | +6K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Jeffrey Landau | SVP, Administration | 3K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SAMANT VIJAY B | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |